Michael Baier

3.1k total citations
57 papers, 2.5k citations indexed

About

Michael Baier is a scholar working on Molecular Biology, Nutrition and Dietetics and Neurology. According to data from OpenAlex, Michael Baier has authored 57 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 20 papers in Nutrition and Dietetics and 18 papers in Neurology. Recurrent topics in Michael Baier's work include Prion Diseases and Protein Misfolding (41 papers), Trace Elements in Health (20 papers) and Neurological diseases and metabolism (17 papers). Michael Baier is often cited by papers focused on Prion Diseases and Protein Misfolding (41 papers), Trace Elements in Health (20 papers) and Neurological diseases and metabolism (17 papers). Michael Baier collaborates with scholars based in Germany, United States and United Kingdom. Michael Baier's co-authors include Constanze Riemer, Anja Schwarz, Michael Burwinkel, Hermann Schätzl, Andreas Heiseke, Yasmine Aguib, Julia Schultz, Reinhard Kurth, N. C. Hughes‐Jones and Andrew D. Griffiths and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Michael Baier

56 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Baier Germany 27 1.8k 630 502 441 438 57 2.5k
Massimo Alessio Italy 30 1.0k 0.6× 265 0.4× 164 0.3× 295 0.7× 199 0.5× 82 2.8k
Fernando Goñi United States 28 868 0.5× 395 0.6× 551 1.1× 778 1.8× 109 0.2× 75 2.3k
Noriyuki Nishida Japan 33 3.4k 1.9× 1.6k 2.5× 131 0.3× 588 1.3× 1.1k 2.4× 105 4.1k
Bert van het Hof Netherlands 32 1.5k 0.8× 826 1.3× 91 0.2× 305 0.7× 128 0.3× 48 3.1k
Sabine Gilch Canada 27 2.3k 1.3× 837 1.3× 83 0.2× 369 0.8× 720 1.6× 75 2.7k
Hermann C. Altmeppen Germany 23 1.1k 0.6× 527 0.8× 78 0.2× 477 1.1× 224 0.5× 53 1.6k
Dhirendra P. Singh United States 38 2.5k 1.4× 115 0.2× 296 0.6× 286 0.6× 192 0.4× 106 3.6k
James M. Staddon United Kingdom 27 1.9k 1.1× 1.3k 2.1× 83 0.2× 441 1.0× 124 0.3× 52 3.7k
Nora Rozengurt United States 27 2.2k 1.2× 115 0.2× 131 0.3× 564 1.3× 645 1.5× 50 4.4k
Sheila P. Little United States 27 1.0k 0.6× 361 0.6× 104 0.2× 397 0.9× 79 0.2× 41 2.7k

Countries citing papers authored by Michael Baier

Since Specialization
Citations

This map shows the geographic impact of Michael Baier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Baier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Baier more than expected).

Fields of papers citing papers by Michael Baier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Baier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Baier. The network helps show where Michael Baier may publish in the future.

Co-authorship network of co-authors of Michael Baier

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Baier. A scholar is included among the top collaborators of Michael Baier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Baier. Michael Baier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burwinkel, Michael, et al.. (2018). Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA). Acta Neuropathologica Communications. 6(1). 23–23. 38 indexed citations
2.
Burwinkel, Michael, et al.. (2015). Ablation of CCAAT/Enhancer-Binding Protein Delta (C/EBPD): Increased Plaque Burden in a Murine Alzheimer’s Disease Model. PLoS ONE. 10(7). e0134228–e0134228. 4 indexed citations
3.
Müller, Veronika, Lisa Marie Munter, Michael Baier, et al.. (2012). The Heat Shock Response Is Modulated by and Interferes with Toxic Effects of Scrapie Prion Protein and Amyloid β. Journal of Biological Chemistry. 287(52). 43765–43776. 8 indexed citations
4.
Aguib, Yasmine, Andreas Heiseke, Sabine Gilch, et al.. (2009). Autophagy induction by trehalose counter-acts cellular prion-infection. Autophagy. 5(3). 361–369. 192 indexed citations
5.
Laue, Michael, et al.. (2009). Prion disease development in slow Wallerian degeneration (WldS) mice. Neuroscience Letters. 456(2). 93–98. 5 indexed citations
6.
Riemer, Constanze, et al.. (2009). Neuroinflammation in Prion Diseases: Concepts and Targets for Therapeutic Intervention. CNS & Neurological Disorders - Drug Targets. 8(5). 329–341. 14 indexed citations
7.
8.
Maddison, Ben C., Shilpa Patel, Roger F.L. James, et al.. (2005). Generation and characterisation of monoclonal antibodies to Rainbow trout (Oncorhynchus mykiss) prion protein. Journal of Immunological Methods. 306(1-2). 202–210. 7 indexed citations
9.
Baier, Michael, Hermann−Georg Holzhütter, Eckart Köttgen, et al.. (2004). Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation. Thrombosis and Haemostasis. 91(3). 465–472. 21 indexed citations
10.
Schultz, Julia, Anja Schwarz, Michael Burwinkel, et al.. (2004). Role of Interleukin-1 in Prion Disease-Associated Astrocyte Activation. American Journal Of Pathology. 165(2). 671–678. 79 indexed citations
11.
Schwarz, Anja, Michael Burwinkel, Constanze Riemer, Julia Schultz, & Michael Baier. (2004). Unchanged Scrapie Pathology in Brain Tissue of Tyrosine Kinase Fyn-Deficient Mice. Neurodegenerative Diseases. 1(6). 266–268. 7 indexed citations
12.
Burwinkel, Michael, et al.. (2004). Role of cytokines and chemokines in prion infections of the central nervous system. International Journal of Developmental Neuroscience. 22(7). 497–505. 36 indexed citations
13.
Schwarz, Anja, Michael Burwinkel, Constanze Riemer, et al.. (2003). Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neuroscience Letters. 350(3). 187–189. 80 indexed citations
14.
Riemer, Constanze, et al.. (2002). BSE, Scrapie, and vCJD: Infectious Neurodegenerative Diseases. PubMed. 85–103. 1 indexed citations
15.
Mr, Bobkova, Michael Baier, Jörn Stitz, et al.. (2000). Targeting Human T Cells by Retroviral Vectors Displaying Antibody Domains Selected from a Phage Display Library. Human Gene Therapy. 11(2). 293–303. 37 indexed citations
16.
Bannert, N, Reinhard Kurth, & Michael Baier. (1999). The gene encoding mouse interleukin-16 consists of seven exons and maps to Chromosome 7 D2-D3. Immunogenetics. 49(7-8). 704–706. 14 indexed citations
17.
Bannert, N, Henric S. Adler, Albrecht Werner, Michael Baier, & Reinhard Kurth. (1998). Molecular cloning and sequence analysis of interleukin 16 from nonhuman primates and from the mouse. Immunogenetics. 47(5). 390–397. 26 indexed citations
18.
Baier, Michael & Reinhard Kurth. (1997). Interleukin-16 for the gene therapy of HIV infection. Expert Opinion on Investigational Drugs. 6(12). 1879–1881. 2 indexed citations
19.
Hawkins, Robert E., Stephen J. Russell, Michael Baier, & Greg Winter. (1993). The Contribution of Contact and Non-contact Residues of Antibody in the Affinity of Binding to Antigen. Journal of Molecular Biology. 234(4). 958–964. 106 indexed citations
20.
Kraus, G, et al.. (1990). Simian immunodeficiency virus reverse transcriptase. European Journal of Biochemistry. 192(1). 207–213. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Alessio Breakdown of academic impact, for papers by Fernando Goñi Breakdown of academic impact, for papers by Noriyuki Nishida Breakdown of academic impact, for papers by Bert van het Hof Breakdown of academic impact, for papers by Sabine Gilch Breakdown of academic impact, for papers by Hermann C. Altmeppen Breakdown of academic impact, for papers by Dhirendra P. Singh Breakdown of academic impact, for papers by James M. Staddon Breakdown of academic impact, for papers by Nora Rozengurt Breakdown of academic impact, for papers by Sheila P. Little
Rankless by CCL
2026